Related Experiment Video
Updated: May 16, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Molecular dynamics simulations of retinoblastoma protein
C Ramakrishnan1, V Subramanian, K Balamurugan
1a Centre of Advanced Study in Crystallography and Biophysics, University of Madras , Maraimalai (Guindy) Campus, Chennai , 600025 , India .
Abstract:
Tumor suppressor proteins play a crucial role in cell cycle regulation. Retinoblastoma protein (pRB) is one among them which regulates G1-S transition by binding with transcription factors. The activity of pRB is deregulated by cyclin dependent kinases-mediated hyper-phosphorylation and also due to cancer-derived mutations. In addition, it is also deactivated by binding of viral onco-proteins such as large T antigen, E1A, and E7. These viral proteins initially recognize pRB through their conserved LxCxE motif and facilitate dissociation of preexisting pRB-E2F complex. Based on these features, molecular dynamics (MD) simulation is performed for four different states of pRB for which the crystal structure is available. The unliganded/apo form and complex forms with E2F and E7 peptides reveal the molecular mechanism behind the activation and inactivation of pRB. In addition, the ternary complex of pRB with both E7 and E2F (for which no crystal structure is available) is modeled and simulated to understand the influence of binding of one ligand on the other. The variations in the three major factors such as conformational changes, inter- and intra-molecular interactions, and binding free energies between the apo and complex forms confirm the possibility for designing a small molecule inhibitor to inhibit pRB-E7 interactions without altering the prebound E2F. The present study deals with the molecular modeling and MD simulations of pRB in free and ligand-bound forms and confirms that pRB could be a valid target for the anticancer drug design when the cancer is induced by the viral onco-proteins and forms a clear base for designing E7 antagonists.
Insights
Retinoblastoma protein (pRB) is vital for cell cycle control but can be inactivated by viral proteins. Molecular dynamics simulations reveal how to design drugs targeting pRB-E7 interactions for anticancer therapies.
Area of Science:
- Molecular biology
- Biochemistry
- Computational biology
Background:
- Tumor suppressor proteins, like Retinoblastoma protein (pRB), are critical for regulating the cell cycle.
- pRB's function is disrupted by cancer mutations and viral oncoproteins (e.g., E7) that bind via a conserved LxCxE motif.
- Viral oncoproteins can displace E2F transcription factors, leading to cell cycle dysregulation.
Purpose of the Study:
- To investigate the molecular mechanisms of pRB activation and inactivation using molecular dynamics (MD) simulations.
- To model and simulate a ternary complex of pRB with E7 and E2F to understand ligand-induced effects.
- To explore the potential of pRB as an anticancer drug target, particularly against viral oncoprotein-induced cancers.
Main Methods:
- MD simulations were performed on four distinct states of pRB, including its unliganded (apo) form and complexes with E2F and E7 peptides.
- A ternary complex of pRB with both E7 and E2F was computationally modeled and simulated.
- Analysis focused on conformational changes, intermolecular/intramolecular interactions, and binding free energies.
Main Results:
- Simulations elucidated the molecular basis for pRB activation and inactivation.
- The study identified key differences between apo and ligand-bound pRB states.
- Results confirmed that pRB-E7 interactions can be inhibited without affecting pRB-E2F binding.
Conclusions:
- pRB is a viable therapeutic target for antiviral oncoprotein-driven cancers.
- The findings provide a foundation for designing specific E7 antagonists.
- Targeting pRB-E7 interactions offers a strategy for developing novel anticancer drugs.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:19Protein Dynamics in Living Cells
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...